Evidence map›Paper›PMID 35976487›Full record

ReviewNeurochemical research2022

Cell Death Mechanisms in Cerebral Ischemia-Reperfusion Injury.

Qian Zhang, Meng Jia, YunFu Wang, Qun Wang, Jianping Wu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. GlyT1 (SLC6A9) inhibition in neurological and psychiatric disorders.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  20. Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qian ZhangSchool of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology, Wuhan, 430070, China.
Meng JiaBeijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
YunFu WangTaihe Hospital, Hubei University of Medicine, Shiyan, 440070, China.
Qun WangBeijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Jianping WuSchool of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology, Wuhan, 430070, China. biojpwu@gmail.com.

Funding

Beijing Natural Science Foundation Z200024Capital Health Research and Development of Special grants 2020-1-2013National Natural Science Foundation of China 81870935Natural Science Foundation of Beijing 7214224
6 · The paper itself

Abstract

Ischemic stroke is one of the major causes of morbidity and mortality, affecting millions of people worldwide. Inevitably, the interruption of cerebral blood supply after ischemia may promote a cascade of pathophysiological processes. Moreover, the subsequent restoration of blood flow and reoxygenation may further aggravate brain tissue injury. Although recombinant tissue plasminogen activator (rt-PA) is the only approved therapy for restoring blood perfusion, the reperfusion injury and the narrow therapeutic time window restrict its application for most stroke patients. Increasing evidence indicates that multiple cell death mechanisms are relevant to cerebral ischemia-reperfusion injury, including apoptosis, necrosis, necroptosis, autophagy, pyroptosis, ferroptosis, and so on. Therefore, it is crucial to comprehend various cell death mechanisms and their interactions. In this review, we summarize the various signaling pathways underlying cerebral ischemia-reperfusion injury and elaborate on the crosstalk between the different mechanisms.

Indexed as

Brain IschemiaReperfusion InjuryStrokeCell DeathHumansNecrosisTissue Plasminogen ActivatorTissue Plasminogen ActivatorApoptosisAutophagyCerebral ischemia–reperfusionNecroptosisNecrosis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.